España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Ardelyx
ARDX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.06
-0.66
-11.54%
At close: -
$5.08
0.02
0.40%
After Hours: 7:40 PM EDT
Get Report
Comment
Q4 2024 Earnings were released on Thu Feb 20th, before the market open
The most recent conference call was at 8:00 AM, 2 days ago
Click to view past webcast
Ardelyx (ARDX) Forecast
News
Earnings
Ardelyx (ARDX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Ardelyx (NASDAQ:ARDX) Stock
Ardelyx Stock (NASDAQ: ARDX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 21, 2025
Ardelyx shares are trading lower after Raymon...
Benzinga Newsdesk
Raymond James Reiterates Strong Buy on Ardely...
Benzinga Newsdesk
Breaking Down Ardelyx: 4 Analysts Share Their Views
Benzinga Insights
HC Wainwright & Co. Reiterates Neutral on Ard...
Benzinga Newsdesk
Thursday, February 20, 2025
Palantir Rally Loses Steam, Walmart Outlook Disappoints: What's Driving Markets Thursday?
Erica Kollmann
Ardelyx shares are trading lower. The company...
Benzinga Newsdesk
Ardelyx Expects Full Year 2025 Us Net Product...
Benzinga Newsdesk
Ardelyx Q4 2024 GAAP EPS $0.02 Beats $0.01 Es...
Benzinga Newsdesk
Earnings Scheduled For February 20, 2025
Benzinga Insights
Monday, January 27, 2025
What Analysts Are Saying About Ardelyx Stock
Benzinga Insights
Piper Sandler Maintains Neutral on Ardelyx, R...
Benzinga Newsdesk
Thursday, January 16, 2025
HC Wainwright & Co. Reiterates Neutral on Ard...
Benzinga Newsdesk
Monday, January 13, 2025
Ardelyx shares are trading higher after the c...
Benzinga Newsdesk
Ardelyx Announces 2024 U.S. Sales Of $319M, P...
Benzinga Newsdesk
Thursday, January 02, 2025
Beyond The Numbers: 4 Analysts Discuss Ardelyx Stock
Benzinga Insights
Jefferies Maintains Buy on Ardelyx, Lowers Pr...
Benzinga Newsdesk
Monday, November 11, 2024
HC Wainwright & Co. Downgrades Ardelyx to Neu...
Benzinga Newsdesk
Friday, November 08, 2024
Judge Dismisses Ardelyx Lawsuit Against CMS O...
Benzinga Newsdesk
Monday, November 04, 2024
Citigroup Maintains Buy on Ardelyx, Lowers Pr...
Benzinga Newsdesk
Friday, November 01, 2024
HC Wainwright & Co. Reiterates Buy on Ardelyx...
Benzinga Newsdesk
Thursday, October 31, 2024
Ardelyx Beats Q3 Sales Estimates, Shares Climb
Erica Kollmann
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Ardelyx Q3 Sales $98.24M Beat $86.64M Estimat...
Benzinga Newsdesk
Wednesday, October 30, 2024
Ardelyx's Earnings Outlook
Benzinga Insights
Thursday, October 24, 2024
Ardelyx Shares Additional Data Supporting Fir...
Benzinga Newsdesk
Tuesday, October 15, 2024
Ardelyx To Present Additional Data Supporting...
Benzinga Newsdesk
Wednesday, October 09, 2024
Ardelyx Announces Publication Of A Review Art...
Benzinga Newsdesk
Monday, August 05, 2024
HC Wainwright & Co. Maintains Buy on Ardelyx,...
Benzinga Newsdesk
Friday, August 02, 2024
Citigroup Maintains Buy on Ardelyx, Raises Pr...
Benzinga Newsdesk
What 6 Analyst Ratings Have To Say About Ardelyx
Benzinga Insights
Wedbush Reiterates Outperform on Ardelyx, Mai...
Benzinga Newsdesk
Ardelyx shares are trading higher after the c...
Benzinga Newsdesk
Thursday, August 01, 2024
Ardelyx shares are trading higher after the c...
Benzinga Newsdesk
Ardelyx Q2 2024 GAAP EPS $(0.07) Beats $(0.10...
Benzinga Newsdesk
Wednesday, July 31, 2024
Ardelyx Announces Publication Of Two Plain La...
Benzinga Newsdesk
Thursday, July 18, 2024
HC Wainwright & Co. Reiterates Buy on Ardelyx...
Benzinga Newsdesk
Ardelyx Files Lawsuit Over Medicare Drug Payment Rules, Claims It Will Limit Patient Access To Kidney Disease Treatment
Vandana Singh
Wedbush Reiterates Outperform on Ardelyx, Mai...
Benzinga Newsdesk
Wednesday, July 03, 2024
Citigroup Maintains Buy on Ardelyx, Lowers Pr...
Benzinga Newsdesk
Tuesday, July 02, 2024
Why Ardelyx Stock Is Dropping
Erica Kollmann
Ardelyx shares are trading lower after the co...
Benzinga Newsdesk
To Preserve Patient Access To Xphozah (Tenapa...
Benzinga Newsdesk
Friday, June 28, 2024
Ardelyx shares are trading higher after the c...
Benzinga Newsdesk
Ardelyx Presents Additional Data Detailing Ed...
Benzinga Newsdesk
Thursday, June 20, 2024
Analyst Expectations For Ardelyx's Future
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk
Tuesday, June 04, 2024
How Is The Market Feeling About Ardelyx?
Benzinga Insights
Friday, May 24, 2024
Ardelyx shares are trading lower after the co...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Ardelyx...
Benzinga Newsdesk
Watching Ardelyx Shares; Hearing Traders Circ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
